16:10 EDT Viridian Therapeutics files to sell 244K shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VRDN:
- Viridian Therapeutics management to meet virtually with Jefferies
- Viridian Therapeutics’ VRDN-001 data may keep enthusiasm in check, says RBC
- Viridian Therapeutics price target lowered to $45 from $48 at Wedbush
- Viridian Tanks Despite Positive Data in Thyroid Eye Disease
- Viridian reports ‘positive’ preliminary data from Phase 1/2 VRDN-001 trial